You haven't searched anything yet.
About KalVista Pharmaceuticals
KalVista Pharmaceuticals, Inc. (http://www.kalvista.com) is focused on the discovery, development, and commercialization of novel, oral therapies for diseases with significant unmet need, with an initial focus on hereditary angioedema (HAE). Listed on the Nasdaq Global Market, our headquarters is located in Cambridge, MA with additional offices and laboratories in Salisbury, UK; Zug, Switzerland; and Salt Lake City, UT.
The company has an R&D team with an established track record in the pharmaceutical development of small molecule protease inhibitors, world-leading expertise in the role of plasma kallikrein in disease, and a management team with the capability to bring small molecules through the clinic to commercialization.
KalVista now seeks an Associate Director, Forecast and Performance Reporting which is critical to the organization's mission as it prepares to commercialize sebetralstat, a novel, oral plasma kallikrein inhibitor. KalVista recently reported positive results from the KONFIDENT phase 3 study which demonstrated that sebetralstat met all efficacy endpoints for the treatment of HAE attacks and the safety profile was comparable to placebo. We plan to submit an NDA in the first half of 2024 with launch in 2025.
As the successful candidate for this position, you will fill a critical operating role within KalVista and be part of the Insight and Analytics Team. You will be a key member of the Insight and Analytics Leadership Team, responsible for developing and implementing forecasting models, delivering performance reporting, and providing insights to the US commercial team. This includes collaboration with the US commercial team to understand business needs, gather necessary information and inputs for reporting, and ensure the accuracy of forecast.
Responsibilities
Requirements
Full Time
Pharmaceutical
$167k-217k (estimate)
03/15/2024
05/09/2024
kalvista.com
KENDALL SQUARE, MA
50 - 100
2004
T ANDREW CROCKETT
$10M - $50M
Pharmaceutical